StockData
ResMed Inc logo

ResMed Inc (RMD) stock

RMDNYSESurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RSMDF
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 21/3012% below fair value
$239.53+0.64 (+0.27%)

Close on Nov 13, 2026Market cap $33.69BP/E 21.8Yield 1.00%

ResMed gross margin

Gross margin is gross profit as a percentage of revenue.

ResMed's gross margin for the twelve months ending Sep 30, 2026 was 61.1%. For fiscal 2026 it was 61.1%, against 59.4% the year before. The highest annual figure on record is 63.7% in fiscal 2014.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2026Jun 30, 202661.1%+1.7
FY2025Jun 30, 202559.4%+2.7
FY2024Jun 30, 202456.7%+0.9
FY2023Jun 30, 202355.8%−0.8
FY2022Jun 30, 202256.6%−1.0
FY2021Jun 30, 202157.5%−0.6
FY2020Jun 30, 202058.1%+0.8
FY2019Jun 30, 201957.3%+0.3
FY2018Jun 30, 201857.0%−1.1
FY2017Jun 30, 201758.1%+0.1
FY2016Jun 30, 201658.0%−2.2
FY2015Jun 30, 201560.2%−3.4
FY2014Jun 30, 201463.7%+1.5
FY2013Jun 30, 201362.1%+2.1
FY2012Jun 30, 201260.0%+0.3
FY2011Jun 30, 201159.6%−0.4
FY2010Jun 30, 201060.0%−0.1
FY2009Jun 30, 200960.1%–

Quarterly gross margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q1 FY2027CQ3 2026Sep 30, 202661.5%+0.3
Q4 FY2026CQ2 2026Jun 30, 202658.8%−2.0
Q3 FY2026CQ1 2026Mar 31, 202662.2%+2.9
Q2 FY2026CQ4 2025Dec 31, 202561.8%+3.2
Q1 FY2026CQ3 2025Sep 30, 202561.2%+2.6
Q4 FY2025CQ2 2025Jun 30, 202560.8%+2.3
Q3 FY2025CQ1 2025Mar 31, 202559.3%+1.5
Q2 FY2025CQ4 2024Dec 31, 202458.6%+3.0
Q1 FY2025CQ3 2024Sep 30, 202458.6%+4.1
Q4 FY2024CQ2 2024Jun 30, 202458.5%+3.5
Q3 FY2024CQ1 2024Mar 31, 202457.9%+2.6
Q2 FY2024CQ4 2023Dec 31, 202355.6%−0.4
Q1 FY2024CQ3 2023Sep 30, 202354.4%−2.5
Q4 FY2023CQ2 2023Jun 30, 202355.0%−2.1
Q3 FY2023CQ1 2023Mar 31, 202355.3%−1.5
Q2 FY2023CQ4 2022Dec 31, 202256.1%−0.3
Q1 FY2023CQ3 2022Sep 30, 202256.9%+0.9
Q4 FY2022CQ2 2022Jun 30, 202257.1%+1.1
Q3 FY2022CQ1 2022Mar 31, 202256.8%−1.4
Q2 FY2022CQ4 2021Dec 31, 202156.4%−1.5
Q1 FY2022CQ3 2021Sep 30, 202156.0%−2.3
Q4 FY2021CQ2 2021Jun 30, 202156.0%−2.3
Q3 FY2021CQ1 2021Mar 31, 202158.2%−0.3
Q2 FY2021CQ4 2020Dec 31, 202057.8%−0.2
Q1 FY2021CQ3 2020Sep 30, 202058.3%+0.8
Q4 FY2020CQ2 2020Jun 30, 202058.3%+1.2
Q3 FY2020CQ1 2020Mar 31, 202058.4%+0.9
Q2 FY2020CQ4 2019Dec 31, 201958.0%+0.5
Q1 FY2020CQ3 2019Sep 30, 201957.5%−0.8
Q4 FY2019CQ2 2019Jun 30, 201957.1%+3.3
Q3 FY2019CQ1 2019Mar 31, 201957.5%−0.7
Q2 FY2019CQ4 2018Dec 31, 201857.5%−0.7
Q1 FY2019CQ3 2018Sep 30, 201858.3%−0.0
Q4 FY2018CQ2 2018Jun 30, 201853.8%−4.4
Q3 FY2018CQ1 2018Mar 31, 201858.2%−0.1
Q2 FY2018CQ4 2017Dec 31, 201758.2%−0.1
Q1 FY2018CQ3 2017Sep 30, 201758.4%–
Q4 FY2017CQ2 2017Jun 30, 201758.2%–
Q3 FY2017CQ1 2017Mar 31, 201758.3%–
Q2 FY2017CQ4 2016Dec 31, 201658.3%–

More ResMed figures

See a number that looks wrong?